Table 2. Association of MMP-9 expression and clinicopathologic findings.
MMP-9 |
MMP-9 at invasive front |
|||||
---|---|---|---|---|---|---|
Positive | Negative | P | Positive | Negative | P | |
Variables | (n=26) | (n=29) | value | (n=22) | (n=33) | value |
Gender | ||||||
Male | 22 | 19 | 0.13 | 18 | 23 | 0.361 |
Female | 4 | 10 | 4 | 10 | ||
Age | ||||||
≦59 | 7 | 9 | 0.562 | 5 | 11 | 0.95 |
60–64 | 8 | 1 | 7 | 2 | ||
65–69 | 5 | 5 | 4 | 6 | ||
70≦ | 6 | 14 | 6 | 14 | ||
Gross features | ||||||
Elevated | 6 | 5 | 0.867 | 5 | 6 | 0.871 |
Flat | 1 | 1 | 1 | 1 | ||
Depressed | 19 | 23 | 16 | 26 | ||
Depth of invasion | ||||||
EP | 1 | 8 | 0.004* | 0 | 9 | 0.001* |
LPM | 2 | 4 | 2 | 4 | ||
MM | 7 | 9 | 5 | 11 | ||
SM | 16 | 8 | 15 | 9 | ||
Differentiation grade | ||||||
SCC (well) | 2 | 8 | 0.003* | 2 | 8 | 0.32 |
SCC (moderately) | 12 | 19 | 12 | 19 | ||
SCC (poorly) | 10 | 1 | 6 | 5 | ||
Others | 2 | 1 | 2 | 1 | ||
Lymphatic permeation | ||||||
Positive | 16 | 5 | 0.001* | 13 | 8 | 0.012* |
Negative | 10 | 24 | 9 | 25 | ||
Venous invasion | ||||||
Positive | 5 | 3 | 0.455 | 5 | 3 | 0.244 |
Negative | 21 | 26 | 17 | 30 | ||
Infiltrative growth pattern | ||||||
α | 11 | 17 | 0.633 | 8 | 20 | 0.298 |
β | 14 | 11 | 13 | 12 | ||
γ | 1 | 1 | 1 | 1 | ||
Nodal metastasis | ||||||
Positive | 9 | 3 | 0.049* | 8 | 4 | 0.047* |
Negative | 17 | 26 | 14 | 29 |
Significant.